Mathias Fasshauer1,2,3, Gerrit Eichner4, Inken Behrendt5. 1. Institute of Nutritional Science, Justus-Liebig-University of Giessen, Goethestr. 55, 35390, Giessen, Germany. 2. Department of Internal Medicine (Endocrinology, Nephrology, and Rheumatology), University of Leipzig, Leipzig, Germany. 3. Leipzig University Medical Center, IFB AdiposityDiseases, Leipzig, Germany. 4. Mathematical Institute, Justus-Liebig-University of Giessen, Giessen, Germany. 5. Institute of Nutritional Science, Justus-Liebig-University of Giessen, Goethestr. 55, 35390, Giessen, Germany. inken.behrendt@ernaehrung.uni-giessen.de.
Abstract
PURPOSE: The impact of gluten intake on metabolic health in subjects without celiac disease is unclear. The present study aimed to assess the association between gluten intake and body fat percentage (primary objective), as well as a broad set of metabolic health markers. METHODS: Gluten intake was estimated in 39,927 participants of the UK Biobank who completed a dietary questionnaire for assessment of previous 24-h dietary intakes. Multiple linear regression analyses were performed between gluten intake and markers of metabolic health with Holm adjustment for multiple comparisons. RESULTS: Median gluten intake was 9.7 g/day (male: 11.7 g/day; female: 8.2 g/day; p < 0.0001). In multiple linear regression analysis, association between gluten intake and percentage body fat was negative in males (β = - 0.028, p = 0.0020) and positive in females (β = 0.025, p = 0.0028). Furthermore, gluten intake was a negative predictor of total cholesterol (male: β = - 0.031, p = 0.0154; female: β = - 0.050, p < 0.0001), high-density lipoprotein cholesterol (male: β = - 0.052, p < 0.0001; female: β = - 0.068, p < 0.0001), and glomerular filtration rate (sexes combined: β = - 0.031, p < 0.0001) in both sexes. In females only, gluten intake was positively associated with waist circumference (β = 0.041, p < 0.0001), waist-to-height ratio (β = 0.040, p < 0.0001), as well as body mass index (β = 0.043, p < 0.0001), and negatively related to low-density lipoprotein cholesterol (β = - 0.035, p = 0.0011). A positive association between gluten intake and triglycerides was observed in males only (β = 0.043, p = 0.0001). CONCLUSION: This study indicates that gluten intake is associated with markers of metabolic health. However, all associations are weak and not clinically meaningful. Limiting gluten intake is unlikely to provide metabolic health benefits for a population in total.
PURPOSE: The impact of gluten intake on metabolic health in subjects without celiac disease is unclear. The present study aimed to assess the association between gluten intake and body fat percentage (primary objective), as well as a broad set of metabolic health markers. METHODS: Gluten intake was estimated in 39,927 participants of the UK Biobank who completed a dietary questionnaire for assessment of previous 24-h dietary intakes. Multiple linear regression analyses were performed between gluten intake and markers of metabolic health with Holm adjustment for multiple comparisons. RESULTS: Median gluten intake was 9.7 g/day (male: 11.7 g/day; female: 8.2 g/day; p < 0.0001). In multiple linear regression analysis, association between gluten intake and percentage body fat was negative in males (β = - 0.028, p = 0.0020) and positive in females (β = 0.025, p = 0.0028). Furthermore, gluten intake was a negative predictor of total cholesterol (male: β = - 0.031, p = 0.0154; female: β = - 0.050, p < 0.0001), high-density lipoprotein cholesterol (male: β = - 0.052, p < 0.0001; female: β = - 0.068, p < 0.0001), and glomerular filtration rate (sexes combined: β = - 0.031, p < 0.0001) in both sexes. In females only, gluten intake was positively associated with waist circumference (β = 0.041, p < 0.0001), waist-to-height ratio (β = 0.040, p < 0.0001), as well as body mass index (β = 0.043, p < 0.0001), and negatively related to low-density lipoprotein cholesterol (β = - 0.035, p = 0.0011). A positive association between gluten intake and triglycerides was observed in males only (β = 0.043, p = 0.0001). CONCLUSION: This study indicates that gluten intake is associated with markers of metabolic health. However, all associations are weak and not clinically meaningful. Limiting gluten intake is unlikely to provide metabolic health benefits for a population in total.
Entities:
Keywords:
Body composition; Dyslipidemia; Gluten; Hypertension; Metabolic health; Obesity
Authors: Bette Liu; Heather Young; Francesca L Crowe; Victoria S Benson; Elizabeth A Spencer; Timothy J Key; Paul N Appleby; Valerie Beral Journal: Public Health Nutr Date: 2011-06-01 Impact factor: 4.022
Authors: Geng Zong; Benjamin Lebwohl; Frank B Hu; Laura Sampson; Lauren W Dougherty; Walter C Willett; Andrew T Chan; Qi Sun Journal: Diabetologia Date: 2018-08-03 Impact factor: 10.122
Authors: Emma Foster; Clement Lee; Fumiaki Imamura; Stefanie E Hollidge; Kate L Westgate; Michelle C Venables; Ivan Poliakov; Maisie K Rowland; Timur Osadchiy; Jennifer C Bradley; Emma L Simpson; Ashley J Adamson; Patrick Olivier; Nick Wareham; Nita G Forouhi; Soren Brage Journal: J Nutr Sci Date: 2019-08-30
Authors: Jessica Voss; Carolin V Schneider; Moritz Kleinjans; Tony Bruns; Christian Trautwein; Pavel Strnad Journal: Sci Rep Date: 2021-10-07 Impact factor: 4.379